N-N-Propylformamide

Suppliers

Names

[ CAS No. ]:
6281-94-3

[ Name ]:
N-N-Propylformamide

[Synonym ]:
Formamide,N-propyl
N-propyl carboxamide
N-N-Propylformamide
N-Propyl-formamide
N-Propyl-formamid
FORMAMIDE,N-n-PROPYL
Ameisensaeure-propylamid

Chemical & Physical Properties

[ Density]:
0.865g/cm3

[ Boiling Point ]:
197.2ºC at 760 mmHg

[ Molecular Formula ]:
C4H9NO

[ Molecular Weight ]:
87.12040

[ Flash Point ]:
96.8ºC

[ Exact Mass ]:
87.06840

[ PSA ]:
29.10000

[ LogP ]:
1.16920

[ Index of Refraction ]:
1.399

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
LQ3325000
CHEMICAL NAME :
Formamide, N-n-propyl-
CAS REGISTRY NUMBER :
6281-94-3
BEILSTEIN REFERENCE NO. :
1739276
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C4-H9-N-O
MOLECULAR WEIGHT :
87.14
WISWESSER LINE NOTATION :
VHM3

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
440 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - somnolence (general depressed activity)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 26,596,1973
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
380 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - somnolence (general depressed activity)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 26,596,1973 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
180 mg/kg/36D-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - other changes in urine composition Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical - Metabolism (Intermediary) - Plasma proteins not involving coagulation
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 26,596,1973

Synthetic Route

Precursor & DownStream

Precursor

  • Propylamine
  • Formic Acid
  • Sodium ethoxide
  • Carbon dioxide
  • Trimethyl orthoformate
  • (Z)-Methanimidic acid
  • propionitrile
  • Ethyl formate
  • Ethyl chloroformate

DownStream

  • Propylamine
  • Methyl-n-propylamine
  • N2-n-propyl-N1,N1-dimethylformamidine
  • N,N-Dimethylformamide
  • tert-Butanol
  • propyl isocyanide

Related Compounds

  • N-methyl-N-propylformamide
  • N-n-propyl-N-formylhydrazine
  • (N,N-bis(2-hydroxyethyl)dithiocarbamato-S,S')dichlorogold(III)
  • N,N-Dipropyldodecanamide
  • N,N-dibenzyl-1-phenyl-ethane-1,2-diamine
  • N,N-Bis(2-methylpropyl)benzenamine
  • 4-(6-oxo-3-(thiophen-2-yl)pyridazin-1(6H)-yl)-N-(4-phenoxyphenyl)butanamide
  • N-[4-(diethylamino)-2-methylphenyl]-4-[6-oxo-3-(thiophen-2-yl)-1,6-dihydropyridazin-1-yl]butanamide
  • N-(2,5-difluorophenyl)-4-[6-oxo-3-(thiophen-2-yl)-1,6-dihydropyridazin-1-yl]butanamide
  • 2-[4-(6-Methyl-1,2,3,4-tetrahydroquinolin-1-yl)-4-oxobutyl]-6-(thiophen-2-yl)-2,3-dihydropyridazin-3-one
  • N-[2-methoxy-5-(trifluoromethyl)phenyl]-4-[6-oxo-3-(thiophen-2-yl)-1,6-dihydropyridazin-1-yl]butanamide
  • 1-(Bromomethyl)-1H-pyrrole-2,5-dione
  • N-(5-acetamido-2-methoxyphenyl)-4-(6-oxo-3-(thiophen-2-yl)pyridazin-1(6H)-yl)butanamide
  • 4-[6-oxo-3-(thiophen-2-yl)-1,6-dihydropyridazin-1-yl]-N-(4-sulfamoylphenyl)butanamide
  • 4-(6-oxo-3-(thiophen-2-yl)pyridazin-1(6H)-yl)-N-(4-sulfamoylphenethyl)butanamide
  • 3-(4-chlorobenzenesulfonyl)-N-[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,3,4-oxadiazol-2-yl]propanamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.